Harel Insurance Investments & Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-802	Closed	-$50K	–	518
2019 Q3	$50K	Hold	802	–	–	﹤0.01%	307
2019 Q2	$57K	Hold	802	–	–	﹤0.01%	289
2019 Q1	$63K	Hold	802	–	–	﹤0.01%	253
2018 Q4	$68K	Buy	+802	New	+$68K	﹤0.01%	270